Neonatal responses to alphaprodine administered during labor
The effect of intravenously administered alphaprodine on newborn Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS) were compared in 30 parturients. Patients in group 1 (n = 15) received 20-40 mg increments of alphaprodine, with a total dose of 39...
Gespeichert in:
Veröffentlicht in: | Anesthesia and analgesia 1986-04, Vol.65 (4), p.392-394 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 394 |
---|---|
container_issue | 4 |
container_start_page | 392 |
container_title | Anesthesia and analgesia |
container_volume | 65 |
creator | MURAKAWA, K ABBOUD, T. K YANAGI, T |
description | The effect of intravenously administered alphaprodine on newborn Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS) were compared in 30 parturients. Patients in group 1 (n = 15) received 20-40 mg increments of alphaprodine, with a total dose of 39.3 +/- 3.7 mg (mean +/- SEM). Group 2 patients (n = 15) received no medication during labor. Apgar scores, neonatal acid-base status, and the NACS were equally good in the two groups. The concentrations of alphaprodine in maternal vein, umbilical vein, and umbilical artery at delivery were measured using a gas-chromographic mass spectrophotometric technique. The results showed an umbilical vein-to-maternal vein ratio of 0.52 +/- 0.09. It is concluded that when administered as in this study, alphaprodine has no adverse effects on the neonate. |
doi_str_mv | 10.1213/00000539-198604000-00017 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1213_00000539_198604000_00017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3954114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-d0d76c346cb9fabbb4d6fd7bf1f32373a29df32ae1e982655e4b835efc0d55393</originalsourceid><addsrcrecordid>eNo9kE1LxDAQhoMo67r6E4QcvEaTpkkT8CKLq8KiFz2XyZdWum1Jugf_vVm3dmCYz3dgHoQwo7esYPyOHkxwTZhWkpa5INlZdYKWTBSSVEKrU7TMPU4KrfU5ukjp-7BClVygBdeiZKxcovtX33cwQoujT0PfJZ_w2GNohy8YYu-azmNwu6Zr0uijd9jtY9N94hZMHy_RWYA2-asprtDH5vF9_Uy2b08v64ctsVzpkTjqKml5Ka3RAYwxpZPBVSawwAtecSi0yxl45rUqpBC-NIoLHyx1Ij_JV0gd79rYpxR9qIfY7CD-1IzWBx71P4965lH_8cjS66N02Judd7NwApDnN9MckoU2ROhsk-Y1JZmkFeO_AXxong</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neonatal responses to alphaprodine administered during labor</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>MURAKAWA, K ; ABBOUD, T. K ; YANAGI, T</creator><creatorcontrib>MURAKAWA, K ; ABBOUD, T. K ; YANAGI, T</creatorcontrib><description>The effect of intravenously administered alphaprodine on newborn Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS) were compared in 30 parturients. Patients in group 1 (n = 15) received 20-40 mg increments of alphaprodine, with a total dose of 39.3 +/- 3.7 mg (mean +/- SEM). Group 2 patients (n = 15) received no medication during labor. Apgar scores, neonatal acid-base status, and the NACS were equally good in the two groups. The concentrations of alphaprodine in maternal vein, umbilical vein, and umbilical artery at delivery were measured using a gas-chromographic mass spectrophotometric technique. The results showed an umbilical vein-to-maternal vein ratio of 0.52 +/- 0.09. It is concluded that when administered as in this study, alphaprodine has no adverse effects on the neonate.</description><identifier>ISSN: 0003-2999</identifier><identifier>EISSN: 1526-7598</identifier><identifier>DOI: 10.1213/00000539-198604000-00017</identifier><identifier>PMID: 3954114</identifier><identifier>CODEN: AACRAT</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adult ; Alphaprodine - adverse effects ; Alphaprodine - metabolism ; Analgesics ; Anesthesia, Obstetrical - adverse effects ; Apgar Score ; Biological and medical sciences ; Female ; Fetus - drug effects ; Humans ; Infant, Newborn ; Labor, Obstetric ; Medical sciences ; Neuropharmacology ; Pharmacology. Drug treatments ; Pregnancy</subject><ispartof>Anesthesia and analgesia, 1986-04, Vol.65 (4), p.392-394</ispartof><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-d0d76c346cb9fabbb4d6fd7bf1f32373a29df32ae1e982655e4b835efc0d55393</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8616071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3954114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MURAKAWA, K</creatorcontrib><creatorcontrib>ABBOUD, T. K</creatorcontrib><creatorcontrib>YANAGI, T</creatorcontrib><title>Neonatal responses to alphaprodine administered during labor</title><title>Anesthesia and analgesia</title><addtitle>Anesth Analg</addtitle><description>The effect of intravenously administered alphaprodine on newborn Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS) were compared in 30 parturients. Patients in group 1 (n = 15) received 20-40 mg increments of alphaprodine, with a total dose of 39.3 +/- 3.7 mg (mean +/- SEM). Group 2 patients (n = 15) received no medication during labor. Apgar scores, neonatal acid-base status, and the NACS were equally good in the two groups. The concentrations of alphaprodine in maternal vein, umbilical vein, and umbilical artery at delivery were measured using a gas-chromographic mass spectrophotometric technique. The results showed an umbilical vein-to-maternal vein ratio of 0.52 +/- 0.09. It is concluded that when administered as in this study, alphaprodine has no adverse effects on the neonate.</description><subject>Adult</subject><subject>Alphaprodine - adverse effects</subject><subject>Alphaprodine - metabolism</subject><subject>Analgesics</subject><subject>Anesthesia, Obstetrical - adverse effects</subject><subject>Apgar Score</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Fetus - drug effects</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Labor, Obstetric</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><issn>0003-2999</issn><issn>1526-7598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAQhoMo67r6E4QcvEaTpkkT8CKLq8KiFz2XyZdWum1Jugf_vVm3dmCYz3dgHoQwo7esYPyOHkxwTZhWkpa5INlZdYKWTBSSVEKrU7TMPU4KrfU5ukjp-7BClVygBdeiZKxcovtX33cwQoujT0PfJZ_w2GNohy8YYu-azmNwu6Zr0uijd9jtY9N94hZMHy_RWYA2-asprtDH5vF9_Uy2b08v64ctsVzpkTjqKml5Ka3RAYwxpZPBVSawwAtecSi0yxl45rUqpBC-NIoLHyx1Ij_JV0gd79rYpxR9qIfY7CD-1IzWBx71P4965lH_8cjS66N02Judd7NwApDnN9MckoU2ROhsk-Y1JZmkFeO_AXxong</recordid><startdate>19860401</startdate><enddate>19860401</enddate><creator>MURAKAWA, K</creator><creator>ABBOUD, T. K</creator><creator>YANAGI, T</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19860401</creationdate><title>Neonatal responses to alphaprodine administered during labor</title><author>MURAKAWA, K ; ABBOUD, T. K ; YANAGI, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-d0d76c346cb9fabbb4d6fd7bf1f32373a29df32ae1e982655e4b835efc0d55393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adult</topic><topic>Alphaprodine - adverse effects</topic><topic>Alphaprodine - metabolism</topic><topic>Analgesics</topic><topic>Anesthesia, Obstetrical - adverse effects</topic><topic>Apgar Score</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Fetus - drug effects</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Labor, Obstetric</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MURAKAWA, K</creatorcontrib><creatorcontrib>ABBOUD, T. K</creatorcontrib><creatorcontrib>YANAGI, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Anesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MURAKAWA, K</au><au>ABBOUD, T. K</au><au>YANAGI, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neonatal responses to alphaprodine administered during labor</atitle><jtitle>Anesthesia and analgesia</jtitle><addtitle>Anesth Analg</addtitle><date>1986-04-01</date><risdate>1986</risdate><volume>65</volume><issue>4</issue><spage>392</spage><epage>394</epage><pages>392-394</pages><issn>0003-2999</issn><eissn>1526-7598</eissn><coden>AACRAT</coden><abstract>The effect of intravenously administered alphaprodine on newborn Apgar scores, neonatal acid-base status, and the Neurologic and Adaptive Capacity Scoring System (NACS) were compared in 30 parturients. Patients in group 1 (n = 15) received 20-40 mg increments of alphaprodine, with a total dose of 39.3 +/- 3.7 mg (mean +/- SEM). Group 2 patients (n = 15) received no medication during labor. Apgar scores, neonatal acid-base status, and the NACS were equally good in the two groups. The concentrations of alphaprodine in maternal vein, umbilical vein, and umbilical artery at delivery were measured using a gas-chromographic mass spectrophotometric technique. The results showed an umbilical vein-to-maternal vein ratio of 0.52 +/- 0.09. It is concluded that when administered as in this study, alphaprodine has no adverse effects on the neonate.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>3954114</pmid><doi>10.1213/00000539-198604000-00017</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2999 |
ispartof | Anesthesia and analgesia, 1986-04, Vol.65 (4), p.392-394 |
issn | 0003-2999 1526-7598 |
language | eng |
recordid | cdi_crossref_primary_10_1213_00000539_198604000_00017 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete |
subjects | Adult Alphaprodine - adverse effects Alphaprodine - metabolism Analgesics Anesthesia, Obstetrical - adverse effects Apgar Score Biological and medical sciences Female Fetus - drug effects Humans Infant, Newborn Labor, Obstetric Medical sciences Neuropharmacology Pharmacology. Drug treatments Pregnancy |
title | Neonatal responses to alphaprodine administered during labor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A56%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neonatal%20responses%20to%20alphaprodine%20administered%20during%20labor&rft.jtitle=Anesthesia%20and%20analgesia&rft.au=MURAKAWA,%20K&rft.date=1986-04-01&rft.volume=65&rft.issue=4&rft.spage=392&rft.epage=394&rft.pages=392-394&rft.issn=0003-2999&rft.eissn=1526-7598&rft.coden=AACRAT&rft_id=info:doi/10.1213/00000539-198604000-00017&rft_dat=%3Cpubmed_cross%3E3954114%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3954114&rfr_iscdi=true |